+924.9%
MRNA vs FANG
+32.1%
+892.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FANG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.5% | -1.8% | -4.7% | -7.3% |
| 7D | +8.4% | -13.0% | +21.4% | +2.5% |
| 30D | +28.8% | -2.9% | +31.7% | +28.0% |
| 3M | +329.2% | -3.0% | +332.2% | +319.5% |
| 6M | +416.9% | -11.9% | +428.9% | +410.5% |
| YTD | +718.8% | +21.5% | +697.3% | +677.7% |
| 1Y | +924.9% | +34.0% | +890.9% | +770.9% |
| All | +924.9% | +32.1% | +892.8% | +770.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FANG.
Daily Out/Under-Performance
Portfolio return minus FANG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FANG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FANG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling